ArticleActa pharmacologica Sinica2025

Celastrol inhibits the DPYSL2-JAK/STAT pathway by targeting mito-IDHs mediated mitochondrial metabolism to exhaust breast cancer.

Qiao-Li Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.